BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 447211)

  • 1. Cimetidine and L-dopa in the control of prolactin secretion in man.
    Pontiroli AE; Pellicciotta G; Alberetto M; De Pasqua A; Girardi AM; Pozza G
    Horm Metab Res; 1979 Mar; 11(3):257-8. PubMed ID: 447211
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
    Gonzalez-Villapando C; Szabo M; Frohman LA
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1417-24. PubMed ID: 7440704
    [No Abstract]   [Full Text] [Related]  

  • 3. Cimetidine effects on prolactin release and production.
    Barber SG; Hoare AM
    Horm Metab Res; 1979 Mar; 11(3):220-1. PubMed ID: 447203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine on prolactin-secretion and glucose tolerance in men.
    Eversmann T; Landgraf R; Londong W; von Werder K
    Horm Metab Res; 1979 Jun; 11(6):412-3. PubMed ID: 468105
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolactin response to TRH after intravenous cimetidine.
    Scarpignato C; Bertaccini G; Ceda GP; Valenti G
    Farmaco Sci; 1979 Aug; 34(8):726-8. PubMed ID: 111967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
    Lissoni P; Malugani F; Casu M; Bukovec R; Egardi R; Bordin V; Fumagalli E; Mengo S; Gardani G
    Neuro Endocrinol Lett; 2002 Feb; 23(1):61-3. PubMed ID: 11880864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated cimetidine administration reduces the growth hormone (GH) response to insulin-hypoglycemia.
    Pontiroli AE; Pellicciotta G; Alberetto M; de Castro e Silva E; De Pasqua A; Girardi AM; Pozza G
    Horm Metab Res; 1980 Apr; 12(4):172-3. PubMed ID: 6993322
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-DOPA and dopamine loading test].
    Kato Y
    Nihon Rinsho; 1979 Jun; Suppl():2481-2. PubMed ID: 491194
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cimetidine and ranitidine on gastric transmural potential difference and on prolactin secretion in man.
    von Kleist D; Gräf KJ; Dougherty FC; Hampel KE
    Hepatogastroenterology; 1981 Aug; 28(4):210-2. PubMed ID: 6115806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cimetidine and prolactin: a study with dihydroergocristine.
    Poli M; Caviezel F; Bosi E; Murari M; Bonetti M
    Horm Metab Res; 1982 Nov; 14(11):616-7. PubMed ID: 6818118
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of cimetidine on the cardiovascular system of normal subjects].
    Perugini P; Berisso MZ; Chiarella F; Caponnetto S
    Arch Sci Med (Torino); 1980; 137(4):725-30. PubMed ID: 7247696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
    Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y
    Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral cimetidine does not induce hypersecretion of prolactin].
    Pomier-Layrargues G; Cuilleret G; Bories P; Champ C; Orsetti A; Michel H
    Gastroenterol Clin Biol; 1981 Dec; 5(12):1203-4. PubMed ID: 7319219
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma testosterone during bicycle ergometer exercise without and after L-dopa pretreatment.
    Jezová-Repceková D; Vigas M; Mikulaj L; Jurcovicová J
    Endocrinol Exp; 1982 Mar; 16(1):3-8. PubMed ID: 6978249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of impromidine and pentagastrin on gastric output of histamine, acid and pepsin in man.
    Peden NR; Boyd EJ; Callachan H; Shepherd DM; Wormsley KG
    Hepatogastroenterology; 1982 Feb; 29(1):30-4. PubMed ID: 6212525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention with sulpiride of the inhibitory effect of L-DOPA on prolactin secretion].
    Rolandi E; Barreca T; Masturzo P; Polleri A
    Boll Soc Ital Biol Sper; 1975 Jun; 51(12):751-4. PubMed ID: 1222097
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effects of l-dopa administration on the prolactin levels in short-stature subjects].
    Saggese G; Cesaretti G; Carlotti C; Cioni C; Bracaloni C
    Minerva Pediatr; 1992 Mar; 44(3):73-8. PubMed ID: 1518496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: The importance of intracerebral decarboxylation of L-DOPA in the suppression of prolactin secretion.
    Franks S; Lawton NF; Marshall NJ
    J Physiol; 1975 Nov; 252(2):52P-54P. PubMed ID: 1206543
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolactin response to thyrotropin-releasing hormone and cimetidine in patients with severe liver disease.
    Lampertico M; Monza GC; Neri V; Picozzi R; Tarolo GL; Broggi A
    J Nucl Med Allied Sci; 1981; 25(1-2):19-25. PubMed ID: 6788910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.